Libido pill's risks have insurers weighing whether to pay

Published August 19, 2015 This content is archived.

An article on Bloomberg Business about Addyi, the new drug designed to treat low libido in women, quotes Vanessa Barnabei, director of obstetrics and gynecology at UB. “My guess is that women are going to have to work hard to find providers that are willing to do this,” she said. Articles also appeared in the Indianapolis Business Journal and Chicago Tribune.

http://www.bloomberg.com/news/articles/2015-08-19/libido-pill-s-risks-have-insurers-weighing-whether-to-cover-it

http://www.ibj.com/articles/54520-anthem-to-cover-libido-pill-other-insurers-weighing-decision

http://www.chicagotribune.com/news/sns-wp-blm-news-bc-fda-insure19-20150819-story.html